» Authors » Michael P LaValley

Michael P LaValley

Explore the profile of Michael P LaValley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 115
Citations 3020
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liew J, Petrow E, Tilley S, LaValley M, Roemer F, Guermazi A, et al.
Ann Rheum Dis . 2025 Jan; 84(1):115-123. PMID: 39874225
Background: Preventing worsening osteoarthritis (OA) in persons with early OA is a major treatment goal. We evaluated if different early OA definitions yielded enough cases of worsening OA within 2-5...
2.
Lui J, Cozzolino M, Winburn M, Trojanowski M, Wiener R, LaValley M, et al.
Int J Cardiol . 2024 Dec; 421():132891. PMID: 39662748
Background: Systemic sclerosis-related pulmonary hypertension (SSc-PH) is a heterogeneous disease, often complicated by concomitant left ventricular (LV) dysfunction. However, the contribution of heterogeneity in LV dysfunction is unclear. The objective...
3.
Shah N, Morone N, Kim E, Ellis T, Cohn E, LaValley M, et al.
Osteoarthr Cartil Open . 2024 Jul; 6(3):100494. PMID: 39021877
Objective: Negative psychological beliefs like fear avoidance and catastrophizing can interfere with exercise engagement in people with knee osteoarthritis (OA). Mindfulness, when integrated with exercise, could potentially address both psychological...
4.
Lui J, Cozzolino M, Winburn M, Trojanowski M, Wiener R, LaValley M, et al.
Chest . 2023 Dec; 165(6):1505-1517. PMID: 38128607
Background: In systemic sclerosis (SSc), pulmonary hypertension remains a significant cause of morbidity and mortality. Although conventionally classified as group 1 pulmonary arterial hypertension, systemic sclerosis-related pulmonary hypertension (SSc-PH) is...
5.
Lui J, Gillmeyer K, Sangani R, Smyth R, Gopal D, Trojanowski M, et al.
Lung . 2023 Nov; 201(6):565-569. PMID: 37957388
We devised a scoring system to identify patients with systemic sclerosis (SSc) at risk for pulmonary hypertension (PH) and predict all-cause mortality. Using 7 variables obtained via pulmonary function testing,...
6.
Vakhshoorzadeh J, Lui J, Sangani R, Trojanowski M, Bujor A, LaValley M, et al.
Respir Med . 2023 Jun; 216:107333. PMID: 37336329
No abstract available.
7.
Lewis C, Segal N, Rabasa G, LaValley M, Williams G, Nevitt M, et al.
Arthritis Care Res (Hoboken) . 2023 May; 75(11):2328-2335. PMID: 37221156
Objective: Hip abductors, important for controlling pelvic and femoral orientation during gait, may affect knee pain. Our objective was to evaluate the relation of hip abductor strength to worsened or...
8.
Girnis J, Cavanaugh J, Baker T, Duncan R, Fulford D, LaValley M, et al.
J Neurol Phys Ther . 2023 Apr; 47(3):146-154. PMID: 37016469
Background And Purpose: Few persons with Parkinson disease (PD) appear to engage in moderate-intensity walking associated with disease-modifying health benefits. How much time is spent walking at lower, yet still...
9.
Rose M, LaValley M, Jafarzadeh S, Costello K, Shah N, Lee S, et al.
J Meas Phys Behav . 2023 Feb; 5(4):294-298. PMID: 36779003
Objective: To examine changes in physical activity, sleep, pain and mood in people with knee osteoarthritis (OA) during the ongoing COVID-19 pandemic by leveraging an ongoing randomized clinical trial (RCT)....
10.
Rose M, Neogi T, Friscia B, Torabian K, LaValley M, Gheller M, et al.
Arthritis Care Res (Hoboken) . 2023 Feb; 75(9):1939-1948. PMID: 36734316
Objective: To assess the reliability of wearable sensors for at-home assessment of walking and chair stand activities in people with knee osteoarthritis (OA). Methods: Baseline data from participants with knee...